Učitavanje...

S-1 in the treatment of pancreatic cancer

S-1 is an oral 5-fluorouracil (5-FU) prodrug, which is designed to improve the antitumor activity of 5-FU by inhibiting dihydropyrimidine dehydrogenase, the key enzyme of 5-FU catabolism. Recently, two important studies on the clinical use of S-1 for pancreatic cancer have been reported from Japan....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Gastroenterol
Glavni autori: Sudo, Kentaro, Nakamura, Kazuyoshi, Yamaguchi, Taketo
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223244/
https://ncbi.nlm.nih.gov/pubmed/25386059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i41.15110
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!